Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation

被引:183
作者
Mogulkoc, N
Brutsche, MH
Bishop, PW
Greaves, SM
Horrocks, AW
Egan, JJ
机构
[1] S Manchester Univ Hosp NHS Trust, NW Lung Res Ctr, Manchester, Lancs, England
[2] S Manchester Univ Hosp NHS Trust, Dept Pathol, Manchester, Lancs, England
[3] S Manchester Univ Hosp NHS Trust, Dept Radiol, Manchester, Lancs, England
关键词
high-resolution computed tomography; idiopathic pulmonary fibrosis; lung transplantation; pulmonary function testing;
D O I
10.1164/ajrccm.164.1.2007077
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Of patients awaiting lung transplantation, the death rates are highest in those with idiopathic pulmonary fibrosis (IPF), suggesting that many IPF patients are referred late for transplantation. Therefore this study was undertaken to evaluate baseline pulmonary function test (PFT) and high-resolution computed tomography (HRCT) fibrosis scores, and the relationship to survival in IPF patients younger than 65 yr of age. A total of 115 patients with usual interstitial pneumonia (UIP) were studied. At presentation to a tertiary referral center, PFT and HRCT data were collected and analyzed for prognostic significance: the primary outcome measure was patient death. Based on the length of the waiting list for transplantation, prediction of 2-yr survival was examined. DLCO percent predicted and HRCT-fibrosis score were found to be independent predictors of survival and in combination gave the best prognostic prediction. The optimal points on the receiver operating characteristic (ROC) curves for discriminating between survivors and nonsurvivors corresponded to 39% DLCO percent predicted, and to a HRCT-fibrosis score of 2.25. The combination of these parameters yielded an optimal point with a specificity and a sensitivity of 84% and 82%, respectively. A model based on a combination of DLCO percent predicted and HRCT-fibrosis score may optimize the timing of referral for transplantation.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 29 条
[1]  
Aris R, 1998, AM J RESP CRIT CARE, V158, P335
[2]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[3]  
COLLETT D, 1994, MODELLING SURVIVAL D, P97
[4]   OBSERVER VARIATION IN PATTERN TYPE AND EXTENT OF DISEASE IN FIBROSING ALVEOLITIS ON THIN-SECTION COMPUTED-TOMOGRAPHY AND CHEST RADIOGRAPHY [J].
COLLINS, CD ;
WELLS, AU ;
HANSELL, DM ;
MORGAN, RA ;
MACSWEENEY, JE ;
DUBOIS, RM ;
RUBENS, MB .
CLINICAL RADIOLOGY, 1994, 49 (04) :236-240
[5]   STANDARDIZATION OF THE MEASUREMENT OF TRANSFER-FACTOR (DIFFUSING-CAPACITY) - REPORT WORKING PARTY STANDARDIZATION OF LUNG-FUNCTION TESTS EUROPEAN-COMMUNITY FOR STEEL AND COAL - OFFICIAL STATEMENT OF THE EUROPEAN RESPIRATORY SOCIETY [J].
COTES, JE ;
CHINN, DJ ;
QUANJER, PH ;
ROCA, J ;
YERNAULT, JC .
EUROPEAN RESPIRATORY JOURNAL, 1993, 6 :41-52
[6]   Priorities for lung transplantation [J].
Dark, JH .
LANCET, 1998, 351 (9095) :4-5
[7]  
Egan JJ, 1998, HOSP MED, V59, P364
[8]   Lung function tests in patients with idiopathic pulmonary fibrosis - Are they helpful for predicting outcome? [J].
Erbes, R ;
Schaberg, T ;
Loddenkemper, R .
CHEST, 1997, 111 (01) :51-57
[9]   Idiopathic pulmonary fibrosis - Predicting response to therapy and survival [J].
Gay, SE ;
Kazerooni, EA ;
Toews, CB ;
Lynch, JP ;
Gross, BH ;
Cascade, PN ;
Spizarny, DL ;
Flint, A ;
Schork, MA ;
Whyte, RI ;
Popovich, J ;
Hyzy, R ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1063-1072
[10]   CHANGES IN PULMONARY-FUNCTION TEST-RESULTS AFTER 1 YEAR OF THERAPY AS PREDICTORS OF SURVIVAL IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS [J].
HANSON, D ;
WINTERBAUER, RH ;
KIRTLAND, SH ;
WU, R .
CHEST, 1995, 108 (02) :305-310